MedTrace Logo

Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants

NCT01456117 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2012-08-08

No results posted yet for this study

Summary

The purpose of this study is to assess the effects of pioglitazone, once daily (QD), on brain hemodynamics in healthy elderly participants.

Conditions

  • Healthy

Interventions

DRUG

Pioglitazone

Pioglitazone once daily for up to 14 days.

DRUG

Pioglitazone

Pioglitazone once daily for up to 14 days.

DRUG

Pioglitazone

Pioglitazone once daily for up to 14 days.

DRUG

Placebo

Pioglitazone matching placebo once daily for up to 14 days.

Sponsors & Collaborators

Principal Investigators

  • Vice President Clinical Science · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
83 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01456117 on ClinicalTrials.gov